Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1995-12-29
2000-12-12
Mertz, Prema
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
424 851, 514 28, 514 12, 514885, 435 6952, 435 711, 435 712, 435 713, 4352402, 4352523, 4353201, 935 11, 935 22, 935 27, 935 66, 935 70, 935 32, A61K 4500
Patent
active
061594636
ABSTRACT:
Purified DNA encoding LCF and the recombinant proteins expressed from such DNA are disclosed. In addition, the invention provides methods for suppressing an LCF-CD4 interaction and screening candidate LCF agonists or antagonists. The invention also provides compositions and methods useful for stimulating proliferation of CD4+ T-cells in a mammal.
REFERENCES:
patent: 4745051 (1988-05-01), Smith et al.
patent: 4863727 (1989-09-01), Zimmerman et al.
patent: 5965120 (1999-10-01), Center et al.
Cunningham et al. (1989) Science vol. 244, pp. 1081-1085..
George et al. (1988) Marcomolecular Sequencing & Synthesis Selected Methods & Applications. Ch. 12, pp. 127-149, Alan R. Liss, Inc, N.Y.
Rosenberg et al. (1984) Science vol. 223 pp. 1412-1415.
Maeda (1989) Ann. Rev. Entomol. vol. 34 pp. 351-372.
Berman, et al., Cellular Immunology, 95:105-112 (1985).
Berman, et al., AM Rev. Respir. Dis., 142:238-257 (1990).
Cambell, "Monoclonal Antibody Technology, The Production and Characterization of Rodent and Human Hybridomas," Elsevier Science Publishers (Amsterdam), pp. 1-4 and 29 (1984).
Center, et al., The Journal of Immunology, 128:2563-2568 (1982).
Cruikshank, et al., The Journal of Immunology, 138:3817-3823 (1987).
Cruikshank, et al., The Journal of Immunology, 146:2928-2934 (1991).
Cruikshank, et al., EMBL Database, Accession No. M90391 (1992).
Cruikshank, et al., The Journal of Immunology, 128:2569-2574 (1982).
Rand, et al., J. Exp. Med., 173:1521-1528 (1991).
Center, et al. (Feb. 1995) "The Lymphocyte Chemoattractant Factor", J. Lab. Clin. Med. 125(2) :167-172.
Cruikshank, et al. (May 24, 1994) "Molecular and Functional Analysis of a Lymphocyte Chemoattractant Factor: Association of Biologic Function with CD4 Expression", Proc. Natl. Acad. Sci. USA 91(11):5109-5113.
(May 1996) "Terminology Note: Interleukin 16 (IL-16)", Eur. J. Immunol. 26(5)1196.
Center David M.
Cruikshank William W.
Kornfeld Hardy
Mertz Prema
Research Corporation Technologies Inc.
LandOfFree
Lymphocyte chemoattractant factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lymphocyte chemoattractant factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphocyte chemoattractant factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-213497